Equities Research Analysts’ Updated EPS Estimates for July 6th (AMGN, BHP, BMY, BVC, CFG, CRSP, EH, ENT, EZJ, FBRT)

Equities Research Analysts’ updated eps estimates for Monday, July 6th:

Amgen (NASDAQ:AMGN) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $350.00 target price on the stock.

BHP Group (LON:BHP) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 3,350 target price on the stock.

Bristol Myers Squibb (NYSE:BMY) had its neutral rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $54.00 target price on the stock.

BATM Advanced Communications (LON:BVC) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Citizens Financial Group (NYSE:CFG) had its neutral rating reaffirmed by analysts at Robert W. Baird. Robert W. Baird currently has a $72.00 target price on the stock.

CRISPR Therapeutics (NASDAQ:CRSP) had its market outperform rating reaffirmed by analysts at Citizens Jmp. The firm currently has a $80.00 price target on the stock.

EHang (NASDAQ:EH) had its underweight rating reaffirmed by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $4.40 price target on the stock, down from their previous price target of $9.70.

Entain (LON:ENT) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 1,000 price target on the stock.

easyJet (LON:EZJ) had its sector perform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 600 target price on the stock.

Franklin BSP Realty Trust (NYSE:FBRT) had its market outperform rating reiterated by analysts at Citizens Jmp. Citizens Jmp currently has a $11.00 target price on the stock.

FirstGroup (LON:FGP) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a GBX 255 price target on the stock.

Frontier IP Group (LON:FIPP) had its house stock rating reaffirmed by analysts at Shore Capital Group Ltd.

Flutter Entertainment (LON:FLTR) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. They currently have a £160 target price on the stock.

Gilead Sciences (NASDAQ:GILD) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $155.00 target price on the stock.

Glencore (LON:GLEN) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. They currently have a GBX 700 target price on the stock.

Opus Genetics (NASDAQ:IRD) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $12.00 target price on the stock.

J.B. Hunt Transport Services (NASDAQ:JBHT) had its underweight rating reiterated by analysts at Morgan Stanley.

JetBlue Airways (NASDAQ:JBLU) had its underperform rating reaffirmed by analysts at Raymond James Financial, Inc..

Johnson Matthey (LON:JMAT) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 2,400 price target on the stock.

Kosmos Energy (LON:KOS) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 210 target price on the stock.

Landstar System (NASDAQ:LSTR) had its underweight rating reaffirmed by analysts at Morgan Stanley.

Merck & Co., Inc. (NYSE:MRK) had its neutral rating reissued by analysts at Cantor Fitzgerald. They currently have a $120.00 price target on the stock.

M&T Bank (NYSE:MTB) had its neutral rating reiterated by analysts at Robert W. Baird. They currently have a $240.00 price target on the stock.

Old Dominion Freight Line (NASDAQ:ODFL) had its equal weight rating reiterated by analysts at Morgan Stanley. They currently have a $245.00 target price on the stock, up from their previous target price of $235.00.

Pets at Home Group (LON:PETS) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a GBX 265 target price on the stock.

Pfizer (NYSE:PFE) had its neutral rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $27.00 target price on the stock.

Regions Financial (NYSE:RF) had its underperform rating reaffirmed by analysts at Robert W. Baird. They currently have a $28.00 target price on the stock.

Revolution Medicines (NASDAQ:RVMD) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $195.00 price target on the stock.

Slide Insurance (NASDAQ:SLDE) had its equal weight rating reiterated by analysts at Morgan Stanley. They currently have a $20.00 price target on the stock, down from their previous price target of $23.00.

Truist Financial (NYSE:TFC) had its equal weight rating reaffirmed by analysts at Morgan Stanley. The firm currently has a $54.00 price target on the stock, down from their previous price target of $62.00.

TG Therapeutics (NASDAQ:TGTX) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $70.00 target price on the stock.

Telix Pharmaceuticals (NASDAQ:TLX) had its outperform rating reiterated by analysts at Wedbush. They currently have a $22.00 target price on the stock.